• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

形态学如何影响肺浸润性鳞状细胞癌的生存

How Morphology Shapes Survival in Invasive Squamous Cell Carcinoma of the Lung.

作者信息

Marghescu Angela-Ștefania, Vlăsceanu Silviu, Preda Mădălina, Mahler Beatrice, Bădărău Ioana Anca, Manolescu Loredana Sabina Cornelia, Țigău Mirela, Teleagă Cristina, Toader Corina Elena, Radu Alexandru Daniel, Stoichiță Alexandru, Costache Mariana

机构信息

Pathological Anatomy Discipline, Faculty of Medicine, Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, Romania.

Department of Research, Marius Nasta Institute of Pneumophthisiology, 050159 Bucharest, Romania.

出版信息

Diagnostics (Basel). 2024 Oct 11;14(20):2264. doi: 10.3390/diagnostics14202264.

DOI:10.3390/diagnostics14202264
PMID:39451586
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11505874/
Abstract

BACKGROUND AND OBJECTIVES

Squamous cell carcinoma (SQCC) represents a significant proportion of human malignancies affecting various anatomical sites, including the lung. Understanding the prognostic factors is crucial for establishing effective risk stratification in these patients, as multiple critical aspects significantly impact overall survival.

MATERIALS AND METHODS

A retrospective study was conducted on 99 patients with operable lung SQCC treated at a tertiary center. The exclusion criteria included patients under 18, those with in situ or metastatic SQCC, and those who received neoadjuvant therapy. The surgical specimens were re-analyzed, and data were collected on multiple variables, including pTNM staging, tumor characteristics, and overall survival (OS). The Kaplan-Meier survival analysis and Cox regression models were used to identify significant prognostic factors.

RESULTS

The Kaplan-Meier analysis showed a median survival of 36 months with a 65.65% mortality rate. Significant factors influencing survival included keratinization, histological grading, tumor size and stage, pleural invasion, tumor cell arrangement, tumor budding, spread through air space (STAS), and mitotic index. A multiple Cox regression highlighted the nonkeratinizing tumors, advanced pT stages, single-cell invasion, and high mitotic index as key predictors of poorer outcomes. The nonkeratinizing tumors showed higher mortality and shorter median survival rates compared to keratinizing tumors. The tumor staging, cell arrangement, and tumor budding significantly impacted the survival curves.

CONCLUSIONS

The study underscores the importance of detailed histopathological evaluations in lung SQCC. The nonkeratinizing tumors, advanced pT stage, single-cell invasion, and high mitotic index were associated with higher hazard rates, emphasizing the need for a comprehensive grading system incorporating these factors to improve prognostic accuracy and guide treatment strategies.

摘要

背景与目的

鳞状细胞癌(SQCC)在影响包括肺部在内的各个解剖部位的人类恶性肿瘤中占相当大的比例。了解预后因素对于在这些患者中建立有效的风险分层至关重要,因为多个关键方面会显著影响总生存期。

材料与方法

对在一家三级中心接受治疗的99例可手术切除的肺鳞状细胞癌患者进行了一项回顾性研究。排除标准包括18岁以下患者、原位或转移性鳞状细胞癌患者以及接受新辅助治疗的患者。对手术标本进行重新分析,并收集包括pTNM分期、肿瘤特征和总生存期(OS)等多个变量的数据。采用Kaplan-Meier生存分析和Cox回归模型来确定显著的预后因素。

结果

Kaplan-Meier分析显示中位生存期为36个月,死亡率为65.65%。影响生存的显著因素包括角化程度、组织学分级、肿瘤大小和分期、胸膜侵犯、肿瘤细胞排列、肿瘤芽生、气腔播散(STAS)和有丝分裂指数。多因素Cox回归突出显示非角化性肿瘤、晚期pT分期、单细胞浸润和高有丝分裂指数是预后较差的关键预测因素。与角化性肿瘤相比,非角化性肿瘤显示出更高的死亡率和更短的中位生存期。肿瘤分期、细胞排列和肿瘤芽生对生存曲线有显著影响。

结论

该研究强调了在肺鳞状细胞癌中进行详细组织病理学评估的重要性。非角化性肿瘤、晚期pT分期、单细胞浸润和高有丝分裂指数与较高的风险率相关,强调需要一个纳入这些因素的综合分级系统,以提高预后准确性并指导治疗策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ff3/11505874/4fd5623b29b2/diagnostics-14-02264-g015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ff3/11505874/95de864cb9fd/diagnostics-14-02264-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ff3/11505874/7d9bfa216cbd/diagnostics-14-02264-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ff3/11505874/fb38808bcbf3/diagnostics-14-02264-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ff3/11505874/ff0c61f19012/diagnostics-14-02264-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ff3/11505874/7847d3329c88/diagnostics-14-02264-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ff3/11505874/843b7ac979dc/diagnostics-14-02264-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ff3/11505874/37d340fd9281/diagnostics-14-02264-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ff3/11505874/f6234729193b/diagnostics-14-02264-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ff3/11505874/ac4e2447c1bd/diagnostics-14-02264-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ff3/11505874/332d7d4a52e4/diagnostics-14-02264-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ff3/11505874/92b391a39c56/diagnostics-14-02264-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ff3/11505874/4e0612a3af1c/diagnostics-14-02264-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ff3/11505874/d27e0f0806ba/diagnostics-14-02264-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ff3/11505874/ca52320ab807/diagnostics-14-02264-g014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ff3/11505874/4fd5623b29b2/diagnostics-14-02264-g015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ff3/11505874/95de864cb9fd/diagnostics-14-02264-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ff3/11505874/7d9bfa216cbd/diagnostics-14-02264-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ff3/11505874/fb38808bcbf3/diagnostics-14-02264-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ff3/11505874/ff0c61f19012/diagnostics-14-02264-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ff3/11505874/7847d3329c88/diagnostics-14-02264-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ff3/11505874/843b7ac979dc/diagnostics-14-02264-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ff3/11505874/37d340fd9281/diagnostics-14-02264-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ff3/11505874/f6234729193b/diagnostics-14-02264-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ff3/11505874/ac4e2447c1bd/diagnostics-14-02264-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ff3/11505874/332d7d4a52e4/diagnostics-14-02264-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ff3/11505874/92b391a39c56/diagnostics-14-02264-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ff3/11505874/4e0612a3af1c/diagnostics-14-02264-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ff3/11505874/d27e0f0806ba/diagnostics-14-02264-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ff3/11505874/ca52320ab807/diagnostics-14-02264-g014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ff3/11505874/4fd5623b29b2/diagnostics-14-02264-g015.jpg

相似文献

1
How Morphology Shapes Survival in Invasive Squamous Cell Carcinoma of the Lung.形态学如何影响肺浸润性鳞状细胞癌的生存
Diagnostics (Basel). 2024 Oct 11;14(20):2264. doi: 10.3390/diagnostics14202264.
2
Comprehensive pathological analyses in lung squamous cell carcinoma: single cell invasion, nuclear diameter, and tumor budding are independent prognostic factors for worse outcomes.肺鳞状细胞癌的综合病理分析:单细胞侵袭、核直径和肿瘤芽生是预后较差的独立预后因素。
J Thorac Oncol. 2014 Aug;9(8):1126-39. doi: 10.1097/JTO.0000000000000253.
3
Tumor spread through air spaces is a useful predictor of recurrence and prognosis in stage I lung squamous cell carcinoma, but not in stage II and III.肿瘤通过气腔播散是 I 期肺鳞癌复发和预后的有用预测指标,但在 II 期和 III 期则不然。
Lung Cancer. 2018 Jun;120:14-21. doi: 10.1016/j.lungcan.2018.03.018. Epub 2018 Mar 20.
4
Comprehensive analysis of spread through air spaces in lung adenocarcinoma and squamous cell carcinoma using the 8th edition AJCC/UICC staging system.肺腺癌和鳞癌中空气传播途径的全面分析,采用第 8 版 AJCC/UICC 分期系统。
BMC Cancer. 2020 Jul 29;20(1):705. doi: 10.1186/s12885-020-07200-w.
5
Proposal of a grading system for squamous cell carcinoma of the lung - the prognostic importance of tumour budding, single cell invasion, and nuclear diameter.提出一种用于肺鳞癌的分级系统 - 肿瘤芽生、单细胞浸润和核直径的预后意义。
Virchows Arch. 2023 Sep;483(3):393-404. doi: 10.1007/s00428-023-03612-8. Epub 2023 Aug 9.
6
Spread Through Air Spaces (STAS) Is an Independent Prognostic Factor in Resected Lung Squamous Cell Carcinoma.气腔播散(STAS)是肺鳞状细胞癌切除术后的独立预后因素。
Cancers (Basel). 2022 May 3;14(9):2281. doi: 10.3390/cancers14092281.
7
Validation of the International Tumor Budding Consensus Conference (ITBCC) 2016 recommendation in squamous cell carcinoma of the lung-a single-center analysis of 354 cases.国际肿瘤芽生共识会议(ITBCC)2016年关于肺鳞状细胞癌的推荐意见的验证——354例单中心分析
Mod Pathol. 2020 May;33(5):802-811. doi: 10.1038/s41379-019-0413-7. Epub 2019 Dec 3.
8
Prognostic factors and survival unique to surgically treated p16+ oropharyngeal cancer.手术治疗 p16+口咽癌的独特预后因素和生存情况。
Laryngoscope. 2012 Sep;122 Suppl 2:S13-33. doi: 10.1002/lary.23493.
9
Prognostic significance of keratinization in nasopharyngeal carcinoma.鼻咽癌中角化的预后意义。
Am J Otolaryngol. 1995 Mar-Apr;16(2):103-8. doi: 10.1016/0196-0709(95)90040-3.
10
Keratinization of Lung Squamous Cell Carcinoma Is Associated with Poor Clinical Outcome.肺鳞状细胞癌的角化与不良临床预后相关。
Tuberc Respir Dis (Seoul). 2017 Apr;80(2):179-186. doi: 10.4046/trd.2017.80.2.179. Epub 2017 Mar 31.

本文引用的文献

1
Navigating the Maze: Exploring Non-Oncological Complexities in Non-Small-Cell Lung Cancer.穿越迷宫:探索非小细胞肺癌中的非肿瘤学复杂性
Cancers (Basel). 2024 May 16;16(10):1903. doi: 10.3390/cancers16101903.
2
The Nine-Year Survival of Patients Operated for Non-Small-Cell Lung Carcinoma in a Tertiary Centre: The Impact of the Tumour Stage and Other Patient-Related Parameters.三级中心接受手术治疗的非小细胞肺癌患者的 9 年生存情况:肿瘤分期和其他患者相关参数的影响。
Medicina (Kaunas). 2024 Feb 28;60(3):415. doi: 10.3390/medicina60030415.
3
Atypical Histopathological Aspects of Common Types of Lung Cancer-Our Experience and Literature Review.
常见类型肺癌的非典型组织病理学特征——我们的经验与文献回顾。
Medicina (Kaunas). 2024 Jan 7;60(1):112. doi: 10.3390/medicina60010112.
4
Online decision tools for personalized survival prediction and treatment optimization in elderly patients with lung squamous cell carcinoma: a retrospective cohort study.在线决策工具在老年肺鳞癌患者中的应用:一项回顾性队列研究,用于个性化生存预测和治疗优化。
BMC Cancer. 2023 Sep 29;23(1):920. doi: 10.1186/s12885-023-11309-z.
5
Proposal of a grading system for squamous cell carcinoma of the lung - the prognostic importance of tumour budding, single cell invasion, and nuclear diameter.提出一种用于肺鳞癌的分级系统 - 肿瘤芽生、单细胞浸润和核直径的预后意义。
Virchows Arch. 2023 Sep;483(3):393-404. doi: 10.1007/s00428-023-03612-8. Epub 2023 Aug 9.
6
The Bidirectional Relationship between Pulmonary Tuberculosis and Lung Cancer.肺结核与肺癌的双向关系。
Int J Environ Res Public Health. 2023 Jan 10;20(2):1282. doi: 10.3390/ijerph20021282.
7
Prediction of immune subtypes and overall survival in lung squamous cell carcinoma.肺鳞状细胞癌免疫亚型及总生存期的预测
Curr Med Res Opin. 2023 Feb;39(2):289-298. doi: 10.1080/03007995.2022.2129231. Epub 2022 Dec 14.
8
Prognostic impact of tumour budding in squamous cell carcinoma of the lung: a systematic review and meta-analysis.肿瘤芽生对肺鳞状细胞癌的预后影响:一项系统评价和荟萃分析
Histopathology. 2023 Mar;82(4):521-530. doi: 10.1111/his.14822. Epub 2022 Oct 26.
9
Cellular dissociation grading on biopsies of pulmonary squamous cell carcinoma provides prognostic information across all stages and is congruent with resection specimen grading.对肺鳞状细胞癌活检进行细胞分离分级可提供各期的预后信息,与切除标本分级一致。
J Pathol Clin Res. 2022 Nov;8(6):567-578. doi: 10.1002/cjp2.295. Epub 2022 Sep 16.
10
Tumour cell budding and spread through air spaces in squamous cell carcinoma of the lung - Determination and validation of optimal prognostic cut-offs.肿瘤细胞在肺鳞癌中的气腔播散与转移——最佳预后截断值的确定与验证。
Lung Cancer. 2022 Jul;169:1-12. doi: 10.1016/j.lungcan.2022.04.012. Epub 2022 May 2.